Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

被引：0
|
作者：
Pandha, S. [1 ]
Heinemann, L. [1 ]
Simpson, G. R. [1 ]
Boxall, A. [1 ]
Relph, K. [1 ]
Morgan, R. [1 ]
机构：
[1] Univ Surrey, Guildford GU2 5XH, Surrey, England
来源：
BRITISH JOURNAL OF SURGERY | 2011年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
下载
收藏
页码：47 / 48
页数：2
相关论文
共 50 条
  • [31] Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
    Shizuko Sei
    Jodie K Mussio
    Quan-en Yang
    Kunio Nagashima
    Ralph E Parchment
    Matthew C Coffey
    Robert H Shoemaker
    Joseph E Tomaszewski
    Molecular Cancer, 8
  • [32] Synergistic mechanisms of oncolytic reovirus with bortezomib in overcoming therapy resistance of multiple myeloma
    Thirukkumaran, Chandini M.
    Shi, Zhong-Qiao
    Luider, Joanne
    Kopciuk, Karen
    Neri, Paola
    Bahlis, Nizar
    Morris, Don
    CANCER RESEARCH, 2015, 75
  • [33] Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
    Sei, Shizuko
    Mussio, Jodie K.
    Yang, Quan-en
    Nagashima, Kunio
    Parchment, Ralph E.
    Coffey, Matthew C.
    Shoemaker, Robert H.
    Tomaszewski, Joseph E.
    MOLECULAR CANCER, 2009, 8
  • [34] Reovirus and other oncolytic viruses for the targeted treatment of cancer
    Vidal, L.
    Yap, T. A.
    White, C. L.
    Twigger, K.
    Hingorani, M.
    Agrawal, V.
    Kaye, S. B.
    Harrington, K. J.
    de Bono, J. S.
    TARGETED ONCOLOGY, 2006, 1 (03) : 130 - 150
  • [35] Reovirus and other oncolytic viruses for the targeted treatment of cancer
    L. Vidal
    T. A. Yap
    C. L. White
    K. Twigger
    M. Hingorani
    V. Agrawal
    S. B. Kaye
    K. J. Harrington
    J. S. de Bono
    Targeted Oncology, 2006, 1 : 130 - 150
  • [36] The effects of oncolytic reovirus in canine lymphoma cell lines
    Hwang, C. C.
    Umeki, S.
    Igase, M.
    Coffey, M.
    Noguchi, S.
    Okuda, M.
    Mizuno, T.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2016, 14 : 61 - 73
  • [37] Intermittent Docetaxel Chemotherapy in Patients With Castrate-resistant Prostate Cancer
    Mountzios, Ioannis
    Bournakis, Evangelos
    Efstathiou, Eleni
    Varkaris, Andreas
    Wen, Sijin
    Chrisofos, Michael
    Deliveliotis, Charalambos
    Alamanis, Christos
    Anastasiou, Ioannis
    Constantinides, Constantine
    Karadimou, Alexandra
    Tsiatas, Marinos
    Papadimitriou, Christos
    Bamias, Aristotelis
    Dimopoulos, Meletios A.
    UROLOGY, 2011, 77 (03) : 682 - 687
  • [38] Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer
    Kume, Haruki
    Kawai, Taketo
    Nagata, Masayoshi
    Azuma, Takeshi
    Miyazaki, Hideyo
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Homma, Yukio
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 303 - 307
  • [39] Docetaxel based chemotherapy in the treatment of patients with castration resistant prostate cancer
    Mangir, N.
    Turkeri, L.
    ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (08): : 515 - 522
  • [40] Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer
    Cheung, F. Y.
    Leung, K. C.
    Ngan, Roger K. C.
    HONG KONG MEDICAL JOURNAL, 2013, 19 (03) : 237 - 241
12345